1. Home
  2. TXG vs DNN Comparison

TXG vs DNN Comparison

Compare TXG & DNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TXG
  • DNN
  • Stock Information
  • Founded
  • TXG 2012
  • DNN 1954
  • Country
  • TXG United States
  • DNN Canada
  • Employees
  • TXG N/A
  • DNN N/A
  • Industry
  • TXG Biotechnology: Laboratory Analytical Instruments
  • DNN Other Metals and Minerals
  • Sector
  • TXG Industrials
  • DNN Basic Materials
  • Exchange
  • TXG Nasdaq
  • DNN Nasdaq
  • Market Cap
  • TXG 1.6B
  • DNN 1.8B
  • IPO Year
  • TXG 2019
  • DNN 1997
  • Fundamental
  • Price
  • TXG $12.86
  • DNN $2.53
  • Analyst Decision
  • TXG Buy
  • DNN Strong Buy
  • Analyst Count
  • TXG 12
  • DNN 2
  • Target Price
  • TXG $13.54
  • DNN $3.00
  • AVG Volume (30 Days)
  • TXG 2.2M
  • DNN 60.8M
  • Earning Date
  • TXG 10-28-2025
  • DNN 11-06-2025
  • Dividend Yield
  • TXG N/A
  • DNN N/A
  • EPS Growth
  • TXG N/A
  • DNN N/A
  • EPS
  • TXG N/A
  • DNN N/A
  • Revenue
  • TXG $644,466,000.00
  • DNN $3,311,190.00
  • Revenue This Year
  • TXG $2.15
  • DNN $187.00
  • Revenue Next Year
  • TXG N/A
  • DNN $52.74
  • P/E Ratio
  • TXG N/A
  • DNN N/A
  • Revenue Growth
  • TXG 2.02
  • DNN 12.14
  • 52 Week Low
  • TXG $6.78
  • DNN $1.08
  • 52 Week High
  • TXG $24.38
  • DNN $2.61
  • Technical
  • Relative Strength Index (RSI)
  • TXG 45.60
  • DNN 64.76
  • Support Level
  • TXG $12.39
  • DNN $2.34
  • Resistance Level
  • TXG $13.39
  • DNN $2.61
  • Average True Range (ATR)
  • TXG 0.61
  • DNN 0.11
  • MACD
  • TXG -0.12
  • DNN 0.02
  • Stochastic Oscillator
  • TXG 21.74
  • DNN 83.06

About TXG 10x Genomics Inc.

10x Genomics Inc is a life science technology company based in the United States. Its solutions include instruments, consumables, and software for analyzing biological systems. The company's integrated solutions include instruments, consumables, and software for analyzing biological systems at a resolution and scale that matches the complexity of biology. Its product offerings include a Chromium platform comprising microfluidic chips and related consumables, Chromium X series, Visium and Xenium platforms, and others, which are predominantly used for the study of biological components. Geographically, the company derives maximum revenue from the United States and the rest from Americas (excluding the United States), Europe, Middle East and Africa, China, and Asia-Pacific (excluding China).

About DNN Denison Mines Corp (Canada)

Denison Mines Corp is a uranium exploration and development company focused on the Athabasca Basin region of northern Saskatchewan, Canada. The company holds a noteworthy 95% interest in its flagship Wheeler River Uranium Project, the undeveloped uranium project located in the infrastructure-rich eastern part of the Athabasca Basin. Additionally, it is involved in mine decommissioning and environmental services through its Closed Mines group, which manages the Elliot Lake reclamation projects and offers third-party post-closure mine care and maintenance services. The Company operates in two main segments: the Mining segment and the Corporate and Other segment. The majority of revenue is generated from the mining segment.

Share on Social Networks: